Patrizia Ferrari

This inventor holds 31 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Cardiovascular Treatments. Top assignees: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., Farmitalia Carlo Erba, Windtree Therapeutics, Inc.. Active years: 1989-2026.

USPTO Granted Patents = 31 (Patent Applications = 3)

% Patents Active = 80.6

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 7)

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 52(Granted Patents)

Location History:

Varese VA, IT (1994)
Varese, IT (1989 - 2023)

Company Filing History:

21 out of 343

Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.

patents

3 out of 208

Farmitalia Carlo Erba

patents

3 out of 6

Windtree Therapeutics, Inc.

patents

4. 1 out of 1

Cvie Therapeutics Limited

Seismic Pharmaceuticals

patent

7. 1 out of 1

Seismic Pharmaceuticals Operations LLC

patent

Years Active: 1989-2026

Loading Chart...

Areas of Expertise:

Heart Failure

SERCA2a Stimulants

Istaroxime

Androstane Derivatives

Pharmacogenomics

Cardiovascular Disorders

Diterpenoid Derivatives

Amino Derivatives

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12697343 - Intravenous istaroxime for the treatment of acute heart failure (2026-08-04),

2. 12503484 - Androstane derivatives with activity as pure or predominantly pure stimulators of SERCA2a for the treatment of heart failure (2025-12-23),

3. 12343350 - Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF) (2025-07-01),

4. 11730746 - 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure (2023-08-22),

5. 11583540 - Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF) (2023-02-21),

6. 11197869 - Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF) (2021-12-14),

7. 9868757 - 5-β, 14-β-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure (2018-01-16),

8. 9408854 - Methods and systems for pharmacogenomic treatment of cardiovascular conditions (2016-08-09),

9. 8822692 - Diterpenoid derivatives endowed of biological properties (2014-09-02),

10. 8664210 - Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders (2014-03-04),

11. 8609644 - Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders (2013-12-17),

12. 8536160 - Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders (2013-09-17),

13. 8022203 - Amino derivatives of beta-homoandrostanes and beta-heteroandrostanes (2011-09-20),

14. 5955632 - Seco-d steroids active on the cardiovascular system, processes for their (1999-09-21),

15. 5792759 - 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl (1998-08-11),

Title: Inventor Patrizia Ferrari: Revolutionizing Technology in Varese

Introduction: Patrizia Ferrari is a pioneering inventor hailing from Varese, Italy, known for her groundbreaking contributions to the field of technology.

Latest Patents: Patrizia Ferrari holds several patents in the realm of artificial intelligence and renewable energy technologies, showcasing her innovative spirit and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Patrizia Ferrari has worked tirelessly to develop cutting-edge solutions that have reshaped industries and improved the lives of many.

Collaborations: Throughout her career, Patrizia Ferrari has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life and make a lasting impact on society.

Conclusion: In conclusion, Patrizia Ferrari stands as a trailblazing inventor whose passion for innovation and dedication to progress continue to inspire generations of inventors and entrepreneurs worldwide.